Exogenous oxidized low-density lipoprotein injures and alters the barrier function of endothelium in rats in vivo

Circulation Research

Volumn 80, Issue 1, 1997, Pages 37-44

  Rangaswamy, Shanthini ^a   Penn, Marc S ^a   Saidel, Gerald M ^a   Chisolm, Guy M ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

atherosclerosis; biological transport; cytotoxicity; lipoprotein, low density; modified; vascular permeability

Indexed keywords

ANTIOXIDANT; CYTOTOXIN; HORSERADISH PEROXIDASE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SOLVENT;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM INJURY; LIPID OXIDATION; MACROMOLECULE; MALE; MATHEMATICAL MODEL; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT;

EID: 0031015287     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.1.37     Document Type: Article

References (72)

1. Witztum JL, Steinberg D, Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785- 1792.
2. Steinbrecher UP, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med. 1990;9:155-168.
3. Chisolm GM, Penn MS. Oxidized lipoproteins and atherosclerosis. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. New York, NY: Raven Press Publishers: 1996:129-149.
4. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A. 1984;81:3883-3887.
5. Morel DW, DiCorleto PE, Chisolm GM, Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 1984;4:357-364.
6. Cathcart MK, Morel DW, Chisolm GM. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukoc Biol. 1985;38:341-350.
7. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest. 1984;74:1890-1894.
8. Hodis HN, Kramsch DM, Avogaro P, Bittolo-Bon G, Cazzolato G, Hwang J, Peterson H, Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J Lipid Res. 1994;35:669-677.
9. Daugherty A, Zwiefel BS, Sobel BE, Schonfeld G. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis. 1988;8:768-777.
10. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 1988;241:215-218.
11. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
12. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1987;84: 5928-5931.
13. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A. 1987;84:7725-7729.
14. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary disease in men. N Engl J Med. 1993;328:1450-1456.
15. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
16. Shaish A, Daugherty A, O'Sullivan F, Schonfeld G, Heinecke JW. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest. 1995;96:2075-2082.
17. Chang MY, Sasahara M, Chait A, Raines EW, Ross R. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol, II: cellular composition and proliferation. Arterioscler Thromb Vasc Biol. 1995;15:1631-1640.
18. Sasahara M, Raines EW, Chait A, Carew TE, Steinberg D, Wahl PW, Ross R. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol, I: is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest. 1994;94:155-164.
19. Kosugi K, Morel DW, DiCorleto PE, Chisolm GM. Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle. J Cell Physiol. 1987;130:311-320.
20. Cathcart MK, McNally AK, Chisolm GM. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J Lipid Res. 1991:32:63-70.
21. Negre-Salvayre A, Lopez M, Levade T, Pieraggi M-T, Dousset N, Douste-Blazy L, Salvayre R. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cell, II: uptake and cytotoxicity of ultraviolet-treated LDL on lymphoid cell lines. Biochem Biophys Acta. 1990;1045:224-232.
22. Thomas JP, Geiger PG, Girotti AW. Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. J Lipid Res. 1993;34:479-490.
23. Morel DW, Chisolm GM. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res. 1989;30:1827-1834.
24. Coffey MD, Cole RA, Colles SM, Chisolm GM. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. J Clin Invest. 1995;96:1866-1873.
25. Colles SM. Irwin KC, Chisolm GM. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7β-hydroperoxycholesterol. J Lipid Res. 1996;37:2018-2028.
26. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
27. DiCorleto PE, Chisolm GM. Participation of the endothelium in the development of the atherosclerotic plaque. Prog Lipid Res. 1986;25:365-374.
28. Davies PF, Selden SC, Schwartz SM. Enhanced rates of fluid pinocytosis during exponential growth and monolayer regeneration by cultured arterial endothelial cells. J Cell Physiol. 1980;102:119-127.
29. Lin SJ, Jan KM, Chien S. Role of dying endothelial cells in transendothelial macromolecular transport. Arteriosclerosis, 1990;10:703-709.
30. Lin SJ, Jan KM, Weinbaum S, Chien S. Transendothelial transport of low density lipoprotein in association with cell mitosis in rat aorta. Arteriosclerosis. 1989;9:230-236.
31. Hatch FT. Lees RS. Practical methods for plasma lipoprotein analysis. Adv Lipid Res. 1968;6:1-68.
32. Peterson GL, A simplification of the protein assay method of Lowry et al which is more generally applicable. Anal Biochem. 1977;83:346-356.
33. Freeman M, Ekkel Y, Rohrer L, Penman M, Freedman NJ, Chisolm GM, Krieger M. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1991;88:4931-4935.
34. Hessler JR, Morel DW, Lewis LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 1983;3:215-222.
35. el-Saadani M, Esterbauer H, el-Sayed M, Goher M, Nassar AY, Jürgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res. 1989;30:627-630.
36. Morel DW, DiCorleto PE, Chisolm GM. Modulation of endotoxin-induced endothelial cell toxicity by low density lipoprotein. Lab Invest. 1986;55:419-426.
37. Shankar R, de la Motte CA, DiCorleto PE. Thrombin stimulates PDGF production and monocyte adhesion through distinct intracellular pathways in human endothelial cells. Am J Physiol. 1992;262:C199-C206.
38. Shirhatti V, Krishna G. A simple and sensitive method for monitoring drug-induced cell injury in cultured cells. Anal Biochem. 1985;147:410-418.
39. Malinauskas RA. The Spatial Association of Hemodynamics With Altered Endothelial Cells and Increased Arterial Permeability. Durham, NC: Duke University: 1993. PhD dissertation.
40. Geyer G, Schmidt HP, Biedermann M. Horseradish peroxidase as a label of injured cells. Histochem J. 1979;11:337-344.
41. Penn MS, Chisolm GM. Relation between lipopolysaccharide-induced endothelial cell injury and entry of macromolecules into the rat aorta in vivo. Circ Res. 1991;68:1259-1269.
42. Hirsch EZ, Martino W, Orr CH, White H, Chisolm GM. A simple, rapid method for the preparation of en face endothelial (Hautchen) monolayers from rat and rabbit aortas. Atherosclerosis. 1980;37:539-548.
43. Hansson GK, Chao S, Schwartz SM, Reidy MA, Aortic endothelial cell death and replication in normal and lipopolysaccharide-treated rats. Am J Pathol. 1985;121:123-127.
44. Reidy MA, Schwartz SM. Endothelial injury and regeneration, IV: endotoxin: a nondenuding injury to aortic endothelium. Lab Invest. 1983;48:25-34.
45. Schwartz SM, Benditt EP. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci U S A. 1976;73:651-653.
46. Schwartz SM, Benditt EP. Aortic endothelial cell replication, I: effects of age and hypertension in the rat. Circ Res. 1977;41:248-255.
47. Penn MS, Koelle MR, Schwartz SM, Chisolm CM. Visualization and quantification of transmural concentration profiles of macromolecules across the arterial wall. Circ Res. 1990;67:11-22.
48. Penn MS, Saidel GM, Chisolm GM. Relative significance of endothelium and internal elastic lamina in regulating the entry of macromolecules into arteries in vivo. Circ Res. 1994;74:74-82.
49. Penn MS, Saidel GM, Chisolm GM. Vascular injury by endotoxin: changes in macromolecular transport parameters in rat aortas in vivo. Am J Physiol. 1992;262:H1563-H1571.
50. Nagelkerke JF, Havekes L, van Hinsbergh VWM, van Berkel TJC. In vivo catabolism of biologically modified LDL. Arteriosclerosis, 1984;4:256-264.
51. Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL: correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 1987;7:135-143.
52. Bratzler RL, Chisolm GM, Colton CK, Smith KA, Zilversmit DB, Lees RS. The distribution of labeled albumin across the rabbit thoracic aorta in vivo. Circ Res. 1977;40:182-190.
53. Chisolm GM, Ma G, Irwin KC, Martin LL, Gunderson KG, Linberg LF, Morel DW, DiCorleto PE. 7β-Hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci U S A. 1994;91:11452-11456.
54. Juul K, Nielsen LB, Munkholm K, Stender S, Nordestgaard BG. Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. Circulation, 1996; 94:1698-1704.
55. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, Fogelman AM. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest. 1991;87:2253-2257.
56. Lehr HA, Frei B, Olofsson AM, Carew TE, Arfors KE. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E, Circulation. 1995;91:1525-1532.
57. Chisolm GM. Oxidized lipoproteins and leukocyte-endothelial interactions: growing evidence for multiple mechanisms. Lab Invest. 1993;68:369-371.
58. Hessler JR, Robertson AL Jr, Chisolm GM. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 1979;32:213-229.
59. Chisolm GM, Cytotoxicity of oxidized lipoproteins. Curr Opin Lipidol. 1991;2:311-316.
60. Henriksen T, Evensen SA, Carlander B. Injury to human endothelial cells in culture induced by low density lipoproteins. Scand J Clin Lab Invest. 1979;39:361-368.
61. Morel DW, Hessler , JR, Chisolin GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res. 1983;24:1070-1076.
62. Nelson E, Gertz SD, Forbes MS, Rennels ML, Heald FP, Kahn MA, Farber TM, Miller E, Husain M, Earl F. Endothelial lesions in the aorta of egg yolk-fed miniature swine: a study by scanning and transmission electron microscopy. Exp Mol Pathol. 1976;25:208-220.
63. Thomas WA, Imai H, Florentin RA, Reiner J, Scott R. Smooth muscle and endothelial cell deaths in atherogenesis studied by autoradiography. Prog Biochem Pharmacol. 1977;13:234-240.
64. Bratzler RL, Chisolm GM, Colton CK, Smith KA, Lees RS. The distribution of labeled low-density lipoprotein across the rabbit thoracic aorta in vivo. Atherosclerosis. 1977;28:289-307.
65. Hoff HF, Gaubatz JW, Gotto AM Jr. Apo B concentration in the normal human aorta. Biochem Biophys Res Commun. 1978;85:1424-1430.
66. Smith EB, Staples EM. Plasma protein concentrations in interstitial fluid from human aortas. Proc R Soc Lond. 1982;217:59-75.
67. Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol-fed rabbits, II: selective retention of LDL vs selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis. 1989;9:908-918.
68. Kao CH, Chen JK, Kuo JS, Yang VC. Visualization of the transport pathways of low density lipoproteins across the endothelial cells in the branched regions of rat arteries. Atherosclerosis, 1995;116:27-41.
69. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990;344:254-257.
70. Hamilton TA, Major JA, Chisolm GM. The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J Clin Invest. 1995;95:2020-2027.
71. Stemerman MB, Morrel EM, Burke KR, Colton CK, Smith KA, Lees RS. Local variation in arterial wall permeability to low density lipoprotein in normal rabbit aorta. Arteriosclerosis. 1986;6:64-69.
72. Fry DL. Mass transport, atherogenesis, and risk. Arteriosclerosis, 1987;7:88-100.